Blood cell activation in myeloproliferative neoplasms

被引：33
作者：
Cervantes, Francisco [1 ]
Arellano-Rodrigo, Eduardo [2 ]
Alvarez-Larran, Alberto [3 ]
机构：
[1] Univ Barcelona, Dept Hematol, Hosp Clin, IDIBAPS, Barcelona, Spain
[2] Hosp Clin Barcelona, Hemostasis Dept, Barcelona, Spain
[3] IMIM, Hosp del Mar, Dept Hematol, Barcelona, Spain
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2009年 / 94卷 / 11期
关键词：
JAK2 V617F MUTATION; ESSENTIAL THROMBOCYTHEMIA; POLYMORPHONUCLEAR LEUKOCYTES; COAGULATION ACTIVATION; POLYCYTHEMIA-VERA; TISSUE FACTOR; MAST-CELLS; PLATELET; EXPRESSION; THROMBOSIS;
D O I：
10.3324/haematol.2009.013375
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1484 / 1488
页数：5
相关论文
共 30 条
[1]   Increased CD11b neutrophil expression in Budd-Chiari syndrome or portal vein thrombosis secondary to polycythaemia vera [J].
Alvarez-Larrán, A ;
García-Pagán, JC ;
Abraldes, JG ;
Arellano, E ;
Reverter, JC ;
Bosch, J ;
Cervantes, F .
BRITISH JOURNAL OF HAEMATOLOGY, 2004, 124 (03) :329-335
[2]   Increased platelet, leukocyte, and coagulation activation in primary myelofibrosis [J].
Alvarez-Larran, Alberto ;
Arellano-Rodrigo, Eduardo ;
Reverter, Juan Carlos ;
Domingo, Abel ;
Villamor, Neus ;
Colomer, Dolors ;
Cervantes, Francisco .
ANNALS OF HEMATOLOGY, 2008, 87 (04) :269-276
[3]  
Arellano-Rodrigo E, 2006, HAEMATOL-HEMATOL J, V91, P169
[4]   Platelet turnover, coagulation factors, and soluble markers of platelet and endothelial activation in essential thrombocythemia: Relationship with thrombosis occurrence and JAK2 V617F allele burden [J].
Arellano-Rodrigo, Eduardo ;
Alvarez-Larran, Alberto ;
Reverter, Juan-Carlos ;
Colorner, Dolors ;
Villarnor, Neus ;
Bellosillo, Beatriz ;
Cervantes, Francisco .
AMERICAN JOURNAL OF HEMATOLOGY, 2009, 84 (02) :102-108
[5]   Increased CD11/CD18 expression and altered metabolic activity on polymorphonuclear leukocytes from patients with polycythemia vera and essential thrombocythernia [J].
Burgaleta, C ;
González, N ;
César, J .
ACTA HAEMATOLOGICA, 2002, 108 (01) :23-28
[6]   Leukocytosis and risk stratification assessment in essential thrombocythemia [J].
Carobbio, Alessandra ;
Antonioli, Elisabetta ;
Guglielmelli, Paola ;
Vannucchi, Alessandro M. ;
Delaini, Federica ;
Guerini, Vittoria ;
Finazzi, Guido ;
Rambaldi, Alessandro ;
Barbui, Tiziano .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (16) :2732-2736
[7]  
CARULLI G, 1995, HEMATOL PATHOL, V9, P37
[8]   Life expectancy and prognostic factors in the classic BCR/ABL-negative myeloproliferative disorders [J].
Cervantes, F. ;
Passamonti, F. ;
Barosi, G. .
LEUKEMIA, 2008, 22 (05) :905-914
[9]   Influence of the JAK2 V617F mutation and inherited thrombophilia on the thrombotic risk among patients with essential thrombocythemia [J].
De Stefano, Valerio ;
Za, Tommaso ;
Rossi, Elena ;
Fiorini, Alessia ;
Ciminello, Angela ;
Luzzi, Claudia ;
Chiusolo, Patrizia ;
Sica, Simona ;
Leone, Giuseppe .
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 (05) :733-737
[10]  
Falanga A, 2000, BLOOD, V96, P4261
123